MedTrace Logo

Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism

NCT03681808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 242

Last updated 2021-01-08

Study results available
· View outcomes & findings →

Summary

Comparing Test Lens for Astigmatism Soft Contact Lens (Test) to 1-Day Control for Astigmatism contact lenses (Control).

Conditions

  • Astigmatism

Interventions

DEVICE

Control

Contact Lens

DEVICE

Test

Soft Contact Lens

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Lindsey Mathew · Bausch Health Companies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2019-12-16
Completion
2019-12-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681808 on ClinicalTrials.gov